Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02033720
Other study ID # 104666
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 4, 2014
Last updated January 9, 2014
Start date January 2014
Est. completion date February 2015

Study information

Verified date January 2014
Source Lawson Health Research Institute
Contact Ahmed F Hegazy, MD, FRCPC
Phone 1(519) 860-4917
Email ahmed.hegazy@londonhospitals.ca
Is FDA regulated No
Health authority Canada: University of Western Ontario
Study type Observational

Clinical Trial Summary

After successful resuscitation from certain types of cardiac arrest, total body cooling is now a well established treatment that improves the chances of the brain recovering. This however, has only been definitively proven after a certain type of cardiac arrest that is "ventricular fibrillation / ventricular tachycardia". The purpose of this study is to explore if total body cooling is beneficial for patients recovering from another type of cardiac arrest that is "pulseless electrical activity".

HYPOTHESIS:

Patients undergoing post-cardiac arrest therapeutic hypothermia have better neurological outcomes if their initial arrest rhythm is pulseless electrical activity (PEA) in comparison to asystole.


Description:

STUDY RATIONALE AND BACKGROUND INFORMATION:

After successful resuscitation from cardiac arrest the body experiences a period of global reperfusion. During this period, patients may show signs of myocardial stunning, lactic acidosis, neurological injury and reperfusion syndrome. This constellation of findings constitutes what is known as post-cardiac arrest syndrome. The brain appears to be one of the most vulnerable organs to injury during this reperfusion phase and varying degrees of cognitive impairment may be the end result. Inducing mild therapeutic hypothermia has been shown to be protective for the brain in this setting and has been demonstrated to improve neurological recovery. The evidence for this however, is only conclusive in cases where the arrest is in a shockable rhythm i.e. pulseless ventricular tachycardia and ventricular fibrillation.

In 2002, two randomized controlled trials were published showing an improvement in neurological outcomes in patients treated with mild therapeutic hypothermia post resuscitation from shockable cardiac arrest. Therapeutic hypothermia has since been widely adopted by most authorities as part of the comprehensive treatment bundle for post cardiac arrest syndrome. Whether there is any benefit for patients arrested in non-shockable rhythms however, is a matter of controversy. Some have reported improved mortality and better neurological outcomes with therapeutic hypothermia in this patient population. Others have reported no benefit or even a trend towards harm. And although the matter remains controversial, the recommendation still stands for therapeutic hypothermia to be offered for all comatose survivors of cardiac arrest whatever the arrest rhythm.

Most previous reports have examined the differences between shockable and non-shockable rhythms in terms of neurological outcome and mortality rates after therapeutic hypothermia. To our knowledge, no study has examined the differences in outcome between the two types of non-shockable rhythms, that is pulseless electrical activity (PEA) and asystole. We hypothesize that during PEA arrests, patients may retain some degree of cerebral perfusion and hence have better neurological outcomes post-resuscitation. That is in contrast to asystole where patients are likely to have no cerebral perfusion. In this study we attempt to detect any possible differences in neurological recovery (as indicated by the Cerebral Performance Category scale on hospital discharge) after therapeutic hypothermia, between patients arrested in PEA arrest and those arrested in asystole.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date February 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Admission to adult ICU (age =18 years) at London Health Sciences Centre

- Primary reason for ICU admission: postcardiac arrest

- Both in-hospital and out-of-hospital cardiac arrest will be included

- ICU admission between Jan 2008 and Dec 2012.

Exclusion Criteria:

- ICU admissions primarily for reasons other than cardiac arrest.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Intervention

Other:
No treatment
No therapeutic hypothermia was induced.
Therapeutic hypothermia
Hypothermia was induced after successful resuscitation from cardiac arrest.

Locations

Country Name City State
Canada University Hospital, London Health Sciences Centre, University of Western Ontario London Ontario
Canada Victoria Hospital, London Health Sciences Centre, University of Western Ontario London Ontario

Sponsors (2)

Lead Sponsor Collaborator
Lawson Health Research Institute University of Western Ontario, Canada

Country where clinical trial is conducted

Canada, 

References & Publications (7)

Arrich J; European Resuscitation Council Hypothermia After Cardiac Arrest Registry Study Group. Clinical application of mild therapeutic hypothermia after cardiac arrest. Crit Care Med. 2007 Apr;35(4):1041-7. — View Citation

Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002 Feb 21;346(8):557-63. — View Citation

Dumas F, Grimaldi D, Zuber B, Fichet J, Charpentier J, Pène F, Vivien B, Varenne O, Carli P, Jouven X, Empana JP, Cariou A. Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation. 2011 Mar 1;123(8):877-86. doi: 10.1161/CIRCULATIONAHA.110.987347. Epub 2011 Feb 14. — View Citation

Hazinski MF, Nolan JP, Billi JE, Böttiger BW, Bossaert L, de Caen AR, Deakin CD, Drajer S, Eigel B, Hickey RW, Jacobs I, Kleinman ME, Kloeck W, Koster RW, Lim SH, Mancini ME, Montgomery WH, Morley PT, Morrison LJ, Nadkarni VM, O'Connor RE, Okada K, Perlman JM, Sayre MR, Shuster M, Soar J, Sunde K, Travers AH, Wyllie J, Zideman D. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010 Oct 19;122(16 Suppl 2):S250-75. doi: 10.1161/CIRCULATIONAHA.110.970897. — View Citation

Holzer M. Targeted temperature management for comatose survivors of cardiac arrest. N Engl J Med. 2010 Sep 23;363(13):1256-64. doi: 10.1056/NEJMct1002402. Review. — View Citation

Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21;346(8):549-56. Erratum in: N Engl J Med 2002 May 30;346(22):1756. — View Citation

Testori C, Sterz F, Behringer W, Haugk M, Uray T, Zeiner A, Janata A, Arrich J, Holzer M, Losert H. Mild therapeutic hypothermia is associated with favourable outcome in patients after cardiac arrest with non-shockable rhythms. Resuscitation. 2011 Sep;82(9):1162-7. doi: 10.1016/j.resuscitation.2011.05.022. Epub 2011 Jun 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Time to obeying commands Total time in days from the cardiac arrest until the patient is able to obey commands, as documented in the patient's chart. Assessed up to 21 days postcardiac arrest No
Other Documented negative neurological prognosticators For patient's in which the reason for withdrawal of life support is poor neurological outcome, the number of negative neurological prognosticators recorded in the chart will be examined.
Examples of negative prognosticators include: negative somatosensory evoked potentials on post arrest day 3, post arrest status epilepticus, absent brain stem reflexes beyond post arrest day 2... etc.
Upon withdrawal of life support, assessed up to 3 months postcardiac arrest No
Other Post arrest neurological investigations (including imaging studies) All neurological investigations done within 21 days from cardiac arrest will be examined including electroencephalograms, somatosensory evoked potentials, brain magnetic resonance imaging, brain computerized tomography (CT) scans... etc. Performed within 21 days from cardiac arrest No
Primary Cerebral performance category score on hospital discharge Neurological outcome on discharge from hospital as defined by the cerebral performance category (CPC) scale. The CPC scale is a 5 point scale. The outcome measure will be dichotomized into good or bad. Good outcome will be equivalent to CPC scores of 1 & 2 (where the patient is independent), and bad outcome will be equivalent to CPC scores of 3, 4 & 5 (where the patient is either dependent or dead).
CPC Scale:
Functioning normally and independent, possibly with a minor disability.
Moderately disabled, still independent.
Conscious but with a severe disability, dependent.
Unconscious (comatose or in a persistent vegetative state).
Brain dead or dead by traditional criteria.
Upon discharge from hospital, assessed up to 36 months postcardiac arrest No
Secondary Hospital length of stay postcardiac arrest Hospital length of stay (LOS) post-cardiac arrest will be calculated from the day of the cardiac arrest to the day of hospital discharge. If prior to the arrest the patient was an inpatient, we will only count the days from the arrest to discharge. Days spent in hospital prior to the arrest will not be included. Days spent in hospital after successful resuscitation from cardiac arrest, assessed up to 36 months from the date of cardiac arrest No
Secondary Intensive care unit length of stay postcardiac arrest The length of stay (LOS) in the intensive care unit (ICU) in days, after successful resuscitation from cardiac arrest. Days spent in the intensive care unit after successful resuscitation from cardiac arrest, assessed up to 36 months from the date of cardiac arrest No
Secondary Neurological status after hospital discharge Neurological status as documented on the patient's first outpatient clinic visit, assessed up to 12 months from hospital discharge. This will be analyzed as a secondary outcome only if enough data is generated on chart review. Assessed up to 12 months from hospital discharge No
See also
  Status Clinical Trial Phase
Completed NCT05997004 - Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy N/A
Recruiting NCT06356207 - Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study
Completed NCT01946776 - Cardiac Arrhythmias in Epilepsy: the CARELINK-study N/A
Active, not recruiting NCT01200667 - uPHI: Wireless Body Area Network Core Technology N/A
Completed NCT01446471 - REASON 1 Trial: Sonography in Cardiac Arrest N/A
Recruiting NCT06167434 - Future Cardiaâ„¢ Insertable Cardiac Monitor in Subjects With Paroxysmal Atrial Fibrillation (First-in-Human Study) N/A
Withdrawn NCT00527709 - Hold Parameters on Likely Cardiovascular Depressant Medications